Grayscale Prices Hyperliquid ETF at 0.29%, Sets HYPG
Grayscale filed an amended S-1 setting a 0.29% sponsor fee and ticker HYPG for its Hyperliquid Staking ETF, below Bitwise’s 0.34% and 21Shares’ 0.30% fees.
Grayscale filed an amended S-1 with the Securities and Exchange Commission on Monday, setting a 0.29% sponsor fee and the ticker HYPG for the Grayscale Hyperliquid Staking ETF. The filing identifies the fund as the third Hyperliquid-focused ETF to seek a U.S. listing.
The fund is structured to provide investors exposure to Hyperliquid, a decentralized derivatives exchange that supports on-chain trading of perpetual futures. Perpetual futures have no expiration date and allow traders to take leveraged positions on asset prices without owning the underlying token.
Grayscale's 0.29% sponsor fee is lower than fees announced by two competing issuers. Bitwise's BHYP opened with a 0% fee for the first month and will charge 0.34% thereafter. 21Shares' THYP carries a 0.30% fee.
ETF analyst James Seyffart posted on X that he expects the Grayscale fund to launch soon, writing, “Launch likely imminent for Grayscale's Hyperliquid ETF,” and adding, “When I say imminent, I mean that I am expecting the launch this week.”
Hyperliquid's native token HYPE had a reported market capitalization of about $16.1 billion. Funds tied to HYPE recorded more than $132 million in cumulative net inflows as of last month.
Last week, the Commodity Futures Trading Commission took actions allowing U.S. firms to offer certain related contracts, creating a path for exchanges and platforms to roll out products tied to crypto derivatives.
Grayscale's amended registration does not set a public launch date. The fee and ticker are part of the firm's launch preparations; the fund remains subject to regulatory approvals and market and listing arrangements.
The content on The Coinomist is for informational purposes only and should not be interpreted as financial advice. While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, or reliability of any content. Neither we accept liability for any errors or omissions in the information provided or for any financial losses incurred as a result of relying on this information. Actions based on this content are at your own risk. Always do your own research and consult a professional. See our Terms, Privacy Policy, and Disclaimers for more details.








